Related Experiment Video
Updated: Jun 23, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379
Oludotun A Phillips1, Leyla H Sharaf
1Kuwait University, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, P.O. Box 24923, Safat 13110, Kuwait. dphillips@hsc.edu.kw
Abstract:
The application, WO2008062379, claims chimeric compounds comprising chemically linked 5-hydroxymethyl-oxazolidinone and tetracyclic-quinolone moieties. The claimed compounds are potent expanded-range antibacterial agents against selected gram-positive and gram-negative bacteria, which may exhibit dual mode of action as inhibitors of topoisomarases IV and protein synthesis. The structures of the compounds suggest that the linkers are chemically and biochemically stable. This application represents part of recently initiated research efforts at Actelion.
Related Concept Videos
Antimicrobial Effectiveness
Production of Antibiotics
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antibiotic Selection
Inhibitors of Bacterial DNA Synthesis
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
